ZEUS System (Zio Watch) vs Fetal EchoScan
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, the ZEUS System (Zio Watch), is designed for long-term continuous cardiac monitoring in adults to detect arrhythmias using a wearable biosensor. In contrast, Tool B, Fetal EchoScan, is an AI-powered ultrasound screening software for the prenatal detection of congenital heart defects in fetuses. While both utilize AI in cardiology, their differing patient populations, monitoring modalities, and specific clinical applications position them as adjacent rather than direct competitors.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
The ZEUS System is designed for long-term continuous cardiac monitoring to detect and characterize Atrial Fibrillation (AFib) and other cardiac arrhythmias in adult patients 22 years or older. Fetal EchoScan, conversely, assists clinicians in the prenatal detection of congenital heart defects (CHDs) during second-trimester anatomic ultrasound screenings in pregnant women aged 18 or older.
The ZEUS System utilizes a wearable biosensor (Zio Watch) to collect continuous ECG and PPG data. In contrast, Fetal EchoScan is software that integrates with existing ultrasound workflows to provide AI-driven support during prenatal ultrasound examinations, using cardiac fetal ultrasound video clips.
The ZEUS System involves a wearable device for data collection, with data processed via a cloud-based system and accessible through a ZioSuite portal and provider mobile app for report interpretation and patient management. Fetal EchoScan is a cloud-based software-only device that integrates directly with existing ultrasound machines and reporting solutions (DICOM compatible), providing real-time analysis and alerts on a cart-side tablet display.
The ZEUS System uses an AI-powered algorithm for advanced arrhythmia detection and analysis, generating clinically actionable reports with high physician agreement (99%). Fetal EchoScan employs AI for automated detection of congenital heart defects and provides real-time guidance and feedback during ultrasound scans to ensure exam completeness and reduce false-negative and false-positive errors.
The ZEUS System offers long-term continuous monitoring for up to 14 days, supported by a patient app for digital symptom logging. Fetal EchoScan provides real-time guidance and analysis during a single prenatal ultrasound examination, assisting clinicians in ensuring comprehensive exams.
The ZEUS System primarily targets Cardiology, Family Medicine, and Internal Medicine. Fetal EchoScan is designed for Cardiology, Maternal-Fetal Medicine, and Radiology specialties.
More Comparisons
Backers
Who funded each tool's parent company.